Catalyst Wire Dossier Catalyst Wire Dossier

CARCIK-CD19 cells (transposon-manipulated allogeneic)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CARCIK-CD19 cells (transposon-manipulated allogeneic), covering 2023-05-06 to 2023-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT [Phase 1, Phase 2]

See pricing